Mon, 18 Mar 2019 12:00:00 EDT Dapagliflozin Plus Pioglitazone in T1DM Condition: Type 1 Diabetes Mellitus Interventions: Drug: Pioglitazone 45 mg; Drug: Placebo Sponsor: The University of Texas Health Science Center at San Antonio Not yet recruiting
Mon, 18 Mar 2019 12:00:00 EDT Evaluation of Coffee Therapy for Improvement of Renal Oxygenation Conditions: Type1diabetes; Type1 Diabetes Mellitus; Diabetic Kidney Disease; Juvenile Diabetes; Diabetic Nephropathies; Diabetes Complications; Diabetes, Autoimmune Intervention: Drug: Starbucks® Cold brew - 325ml bottle Sponsors: University of Colorado Denver School of Medicine Barbara Davis Center; Johns Hopkins University Not yet recruiting
Mon, 18 Mar 2019 12:00:00 EDT RiSE to Prevent Cardiovascular Disease in African Americans Conditions: Atherosclerosis; Stress; Hypertension; Dyslipidemias; Obesity; Diabetes; Coronary Artery Disease Intervention: Behavioral: Resilience, Stress, and Ethnicity (RiSE) Sponsor: Loyola University Recruiting
Fri, 15 Mar 2019 12:00:00 EDT Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention Conditions: Non-Alcoholic Fatty Liver Disease; Obesity, Morbid; Brown Fat; Metabolic Disease; Diabetes Mellitus; Insulin Resistance; Abdominal Subcutaneous Fat Interventions: Procedure: Bariatric surgery; Behavioral: Dietitian led life style modification intervention; Behavioral: Conventional care (control) Sponsor: Chinese University of Hong Kong Recruiting
Fri, 15 Mar 2019 12:00:00 EDT Cocarnit Effects on Macrophages Polarization Conditions: Diabetes Mellitus, Type 2; Diabetes Complications Intervention: Dietary Supplement: Cocarnit Sponsor: Institute for Atherosclerosis Research, Russia Completed
Fri, 15 Mar 2019 12:00:00 EDT Dexcom G6 Intervention Study Condition: Diabetes Mellitus Interventions: Device: Dexcom G6 CGM - Continues Glucose Monitoring sensor system; Diagnostic Test: POC BG - Point-of-Care Blood Glucose monitoring Sponsor: Emory University Not yet recruiting
Fri, 15 Mar 2019 12:00:00 EDT Effect of Empagliflozin on Body Composition and Ketones Conditions: Diabetes Mellitus; Fat; Intolerance, Pancreas Interventions: Drug: Empagliflozin 10 MG; Drug: Hypoglycemics Oral Sponsor: Seoul National University Bundang Hospital Recruiting
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.
Fri, 15 Mar 2019 11:00:00 -0400 FDA allows marketing of new device to help treat carbon monoxide poisoning FDA allows marketing of a new device, ClearMate, intended to be used with patients suffering from carbon monoxide poisoning. This is the first carbon monoxide poisoning device authorized for marketing by the FDA for use in an emergency room setting.
Wed, 13 Mar 2019 09:30:00 -0400 FDA approves a new generic valsartan FDA has approved a new generic of Diovan (valsartan). The agency prioritized the review of this drug application to help relieve a recent shortage of the drug.
